Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 95%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,933
Total Claims
$2.7M
Drug Cost
385
Beneficiaries
$6,916
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 10,307 Psychiatry & Neurology providers
+423%
Cost per patient vs peers
$6,916 vs $1,323 avg
+105%
Brand preference vs peers
10.4% vs 5.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Brand vs Generic
Brand: 1,238 claims · $2.2M
Generic: 10,695 claims · $436K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Paliperidone Palmitate | 186 | $644K |
| Deutetrabenazine | 57 | $421K |
| Paliperidone Palmitate | 31 | $309K |
| Aripiprazole | 76 | $219K |
| Cariprazine Hcl | 132 | $192K |
| Lurasidone Hcl | 56 | $88K |
| Vortioxetine Hydrobromide | 138 | $74K |
| Aripiprazole | 511 | $71K |
| Risperidone Microspheres | 59 | $71K |
| Aripiprazole Lauroxil | 18 | $50K |
| Brexpiprazole | 42 | $49K |
| Lurasidone Hcl | 112 | $47K |
| Paliperidone | 70 | $34K |
| Buprenorphine Hcl/Naloxone Hcl | 129 | $33K |
| Lisdexamfetamine Dimesylate | 66 | $27K |
Prescribing Profile
75
Unique Drugs
31.0
Anomaly Score
Patient Profile
56
Avg Age
58%
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About